Hot Flash Drug Elinzanetant Shows Strong Safety Record in Pooled Analysis of Four Clinical Trials
A pooled analysis of four randomized trials found the dual neurokinin receptor antagonist elinzanetant showed no liver toxicity or cancer ...
A pooled analysis of four randomized trials found the dual neurokinin receptor antagonist elinzanetant showed no liver toxicity or cancer ...
The American College of Physicians now recommends estrogen-based hormone therapy as the first-line treatment for menopausal hot flashes and night ...
Chinese researchers have built an age-specific reference scale for anti-Müllerian hormone using an ultrasensitive assay, enabling more precise assessment of ...
A latent class analysis of the French VICAN5 survey finds that more than a quarter of breast cancer survivors report ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine